Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
+$208M |
| 2 |
Norfolk Southern
NSC
|
+$145M |
| 3 |
Insmed
INSM
|
+$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$136M |
| 5 |
Soleno Therapeutics
SLNO
|
+$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$355M |
| 2 |
Royalty Pharma
RPRX
|
+$334M |
| 3 |
McDonald's
MCD
|
+$198M |
| 4 |
Union Pacific
UNP
|
+$188M |
| 5 |
HES
Hess
HES
|
+$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
TScan Therapeutics
TCRX
$104M
| $4.83M | 0.01% |
3,500,000
| – | – |
|
702
Monro
MNRO
$507M
| $4.82M | 0.01% |
333,000
-860,289
| -72% | -$12.4M |
|
|
DESP
703
DELISTED
Despegar.com
DESP
| $4.81M | 0.01% |
+256,080
| New | +$4.81M |
|
704
Rio Tinto
RIO
$101B
| $4.81M | 0.01% |
80,000
-510,000
| -86% | -$30.6M |
|
705
Vestis
VSTS
$537M
| $4.76M | 0.01% |
480,761
+350,000
| +268% | +$3.47M |
|
706
Century Aluminum
CENX
$2.09B
| $4.73M | 0.01% |
+255,000
| New | +$4.73M |
|
|
INZY
707
DELISTED
Inozyme Pharma
INZY
| $4.7M | 0.01% |
5,160,000
| – | – |
|
708
Dayforce
DAY
$10.9B
| $4.67M | 0.01% |
80,100
-37,200
| -32% | -$2.17M |
|
|
EXE
709
Expand Energy Corporation Common Stock
EXE
$23B
| $4.66M | 0.01% |
+41,900
| New | +$4.66M |
|
710
Sigma Lithium
SGML
$610M
| $4.58M | 0.01% |
440,000
+215,000
| +96% | +$2.24M |
|
711
Ryman Hospitality Properties
RHP
$6.34B
| $4.57M | 0.01% |
50,000
-80,000
| -62% | -$7.32M |
|
712
Cardiff Oncology
CRDF
$136M
| $4.54M | 0.01% |
1,445,000
+152,692
| +12% | +$479K |
|
713
Constellium
CSTM
$2.02B
| $4.45M | 0.01% |
441,500
+142,726
| +48% | +$1.44M |
|
714
Shattuck Labs
STTK
$83.8M
| $4.44M | 0.01% |
4,675,000
| – | – |
|
715
monday.com
MNDY
$9.66B
| $4.26M | 0.01% |
+17,500
| New | +$4.26M |
|
716
Zimmer Biomet
ZBH
$20.3B
| $4.21M | 0.01% |
+37,239
| New | +$4.21M |
|
717
SAP
SAP
$303B
| $4.03M | 0.01% |
+15,000
| New | +$4.03M |
|
|
ESGR
718
DELISTED
Enstar Group
ESGR
| $4.02M | 0.01% |
+12,088
| New | +$4.02M |
|
|
DEC
719
Diversified Energy
DEC
$1.22B
| $3.99M | 0.01% |
+295,000
| New | +$3.99M |
|
720
Community Bank
CBU
$3.13B
| $3.99M | 0.01% |
+70,104
| New | +$3.99M |
|
721
Unity
U
$18.2B
| $3.92M | 0.01% |
+200,000
| New | +$3.92M |
|
722
Noble Corp
NE
$4.82B
| $3.91M | 0.01% |
+165,000
| New | +$3.91M |
|
723
Aligos Therapeutics
ALGS
$74.4M
| $3.84M | 0.01% |
465,000
+140,000
| +43% | +$1.16M |
|
|
MREO
724
Mereo BioPharma
MREO
$283M
| $3.83M | 0.01% |
1,700,756
-7,014,257
| -80% | -$15.8M |
|
725
Kodiak Sciences
KOD
$513M
| $3.72M | 0.01% |
1,325,707
+186,180
| +16% | +$522K |
|